Epidemiological studies have confirmed that genetic variations of IGF-I and IGFBP-3 are associated with an increased risk of common cancers, including PCa, colorectal cancer, lung cancer and breast cancer [13], [14], [15], [16]. This evidence concerns the gene IGFBP3 and cancer.